Hundreds of adults and teenagers in England with rare eye disease Leber's hereditary optic neuropathy (LHON) will soon have ...

For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...

For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...